Your browser doesn't support javascript.
loading
Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients.
Diaz Caballero, Julio; Wheatley, Rachel M; Kapel, Natalia; López-Causapé, Carla; Van der Schalk, Thomas; Quinn, Angus; Shaw, Liam P; Ogunlana, Lois; Recanatini, Claudia; Xavier, Basil Britto; Timbermont, Leen; Kluytmans, Jan; Ruzin, Alexey; Esser, Mark; Malhotra-Kumar, Surbhi; Oliver, Antonio; MacLean, R Craig.
Afiliação
  • Diaz Caballero J; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • Wheatley RM; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • Kapel N; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • López-Causapé C; Servicio de Microbiología, Hospital Universitari Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.
  • Van der Schalk T; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Quinn A; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • Shaw LP; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • Ogunlana L; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK.
  • Recanatini C; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Xavier BB; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Timbermont L; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Kluytmans J; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Ruzin A; Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Esser M; Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Malhotra-Kumar S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Oliver A; Servicio de Microbiología, Hospital Universitari Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.
  • MacLean RC; University of Oxford, Department of Biology, 11a Mansfield Rd, Oxford, UK. craig.maclean@biology.ox.ac.uk.
Nat Commun ; 14(1): 4083, 2023 07 12.
Article em En | MEDLINE | ID: mdl-37438338
Antibiotic resistance poses a global health threat, but the within-host drivers of resistance remain poorly understood. Pathogen populations are often assumed to be clonal within hosts, and resistance is thought to emerge due to selection for de novo variants. Here we show that mixed strain populations are common in the opportunistic pathogen P. aeruginosa. Crucially, resistance evolves rapidly in patients colonized by multiple strains through selection for pre-existing resistant strains. In contrast, resistance evolves sporadically in patients colonized by single strains due to selection for novel resistance mutations. However, strong trade-offs between resistance and growth rate occur in mixed strain populations, suggesting that within-host diversity can also drive the loss of resistance in the absence of antibiotic treatment. In summary, we show that the within-host diversity of pathogen populations plays a key role in shaping the emergence of resistance in response to treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article